Drug intelligence / Profile preview

Univ. of Groningen 15-LOX-1 compound 5i

Development stage: Unknown
Lead developer: University of Groningen

Overview

Univ. of Groningen 15-LOX-1 compound 5i: sourced facts only. name: "In this study, a novel potent 15-LOX-1 inhibitor, 5i, was developed and structure-activity relationships were explored." [PMID:40132494]; target: "In this study, a novel potent 15-LOX-1 inhibitor, 5i, was developed and structure-activity relationships were explored." [PMID:40132494]; developer: "Department of Chemical and Pharmaceutical Biology, Groningen,Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, the Netherlands." [PMID:40132494]

Targets

15-LOX (Lysyl Oxidase)

Beyond the preview

Go deeper on Univ. of Groningen 15-LOX-1 compound 5i.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Univ. of Groningen 15-LOX-1 compound 5i.